ResMed News Breakdown |
| RMD -- USA Stock | USD 102.69 0.56 0.54% |
Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Richland Standard Get full coverage | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Filed transaction by Resmed Inc director. Unconventional Insider trading | |||||||||
Filed transaction by Resmed Inc director. Unconventional Insider trading | |||||||||
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security | |||||||||
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | |||||||||
Build Optimal Portfolios
Diversify Your Portfolio With ResMed
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ResMed to your portfolio
Investors are also looking into
| Purchase by Harbinger Capital Partners Master Fund I Ltd of 181900 shares of Pyxus InternationalOctober 17, 2018 for Harbinger Capital Partners Master Fund I Ltd | |
| Insteel Industries exotic insider transaction detectedOctober 17, 2018 for H Woltz | |
| Sale by Blum Capital Partners Lp of 30200 shares of ITT EducationalOctober 17, 2018 for Blum Capital Partners Lp |
| View All Premium Stories |
ResMed Performance
Performance against DOW
Price Growth (%) |
1 | Payment of 6309 shares by Rob Douglas of ResMed subject to R... | 09/27/2018 |
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com